ID   GABR1_RAT               Reviewed;         960 AA.
AC   Q9Z0U4; O08620; O08621; Q9Z0F9; Q9Z308;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2024, sequence version 2.
DT   02-OCT-2024, entry version 200.
DE   RecName: Full=Gamma-aminobutyric acid type B receptor subunit 1;
DE            Short=GABA-B receptor 1;
DE            Short=GABA-B-R1;
DE            Short=GABA-BR1;
DE            Short=GABABR1;
DE            Short=Gb1;
DE   Flags: Precursor;
GN   Name=Gabbr1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1A AND 1B), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=RICO;
RC   TISSUE=Brain cortex, and Cerebellum {ECO:0000303|PubMed:9069281};
RX   PubMed=9069281; DOI=10.1038/386239a0;
RA   Kaupmann K., Huggel K., Heid J., Flor P.J., Bischoff S., Mickel S.J.,
RA   McMaster G., Angst C., Bittiger H., Froestl W., Bettler B.;
RT   "Expression cloning of GABA(B) receptors uncovers similarity to
RT   metabotropic glutamate receptors.";
RL   Nature 386:239-246(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1C AND 1D), AND TISSUE SPECIFICITY.
RC   TISSUE=Cerebellum {ECO:0000303|PubMed:9875211};
RX   PubMed=9875211; DOI=10.1006/bbrc.1998.9706;
RA   Isomoto S., Kaibara M., Sakurai-Yamashita Y., Nagayama Y., Uezono Y.,
RA   Yano K., Taniyama K.;
RT   "Cloning and tissue distribution of novel splice variants of the rat GABAB
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 253:10-15(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1A; 1B; 1C AND 1E), ALTERNATIVE
RP   SPLICING, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Hippocampus {ECO:0000303|PubMed:10457184};
RX   PubMed=10457184; DOI=10.1046/j.1460-9568.1999.00704.x;
RA   Pfaff T., Malitschek B., Kaupmann K., Prezeau L., Pin J.-P., Bettler B.,
RA   Karschin A.;
RT   "Alternative splicing generates a novel isoform of the rat metabotropic
RT   GABA(B)R1 receptor.";
RL   Eur. J. Neurosci. 11:2874-2882(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1A), AND FUNCTION.
RC   TISSUE=Brain {ECO:0000303|PubMed:10075644};
RX   PubMed=10075644; DOI=10.1074/jbc.274.12.7607;
RA   Ng G.Y.K., Clark J., Coulombe N., Ethier N., Hebert T.E., Sullivan R.,
RA   Kargman S., Chateauneuf A., Tsukamoto N., McDonald T., Whiting P.,
RA   Mezey E., Johnson M.P., Liu Q., Kolakowski L.F. Jr., Evans J.F.,
RA   Bonner T.I., O'Neill G.P.;
RT   "Identification of a GABAB receptor subunit, gb2, required for functional
RT   GABAB receptor activity.";
RL   J. Biol. Chem. 274:7607-7610(1999).
RN   [5]
RP   FUNCTION, INTERACTION WITH GABBR2, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Hypothalamus {ECO:0000303|PubMed:9872315};
RX   PubMed=9872315; DOI=10.1038/25348;
RA   Jones K.A., Borowsky B., Tamm J.A., Craig D.A., Durkin M.M., Dai M.,
RA   Yao W.-J., Johnson M., Gunwaldsen C.A., Huang L.-Y., Tang C., Shen Q.,
RA   Salon J.A., Morse K., Laz T., Smith K.E., Nagarathnam D., Noble S.A.,
RA   Branchek T.A., Gerald C.;
RT   "GABA(B) receptors function as a heteromeric assembly of the subunits
RT   GABA(B)R1 and GABA(B)R2.";
RL   Nature 396:674-679(1998).
RN   [6]
RP   FUNCTION, INTERACTION WITH GABBR2, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain cortex, and Cerebellum {ECO:0000303|PubMed:9872317};
RX   PubMed=9872317; DOI=10.1038/25360;
RA   Kaupmann K., Malitschek B., Schuler V., Heid J., Froestl W., Beck P.,
RA   Mosbacher J., Bischoff S., Kulik A., Shigemoto R., Karschin A., Bettler B.;
RT   "GABA-B receptor subtypes assemble into functional heteromeric complexes.";
RL   Nature 396:683-687(1998).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=10658574; DOI=10.1016/s0968-0896(99)00214-x;
RA   Belley M., Sullivan R., Reeves A., Evans J.F., O'Neill G.P., Ng G.Y.K.;
RT   "Synthesis of the nanomolar photoaffinity GABA(B) receptor ligand CGP 71872
RT   reveals diversity in the tissue distribution of GABA(B) receptor forms.";
RL   Bioorg. Med. Chem. 7:2697-2704(1999).
RN   [8]
RP   FUNCTION, INTERACTION WITH GABBR2, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=9872744; DOI=10.1126/science.283.5398.74;
RA   Kuner R., Koehr G., Gruenewald S., Eisenhardt G., Bach A., Kornau H.-C.;
RT   "Role of heteromer formation in GABAB receptor function.";
RL   Science 283:74-77(1999).
RN   [9]
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain cortex {ECO:0000303|PubMed:10727622};
RX   PubMed=10727622; DOI=10.1016/s0006-8993(00)01958-2;
RA   Clark J.A., Mezey E., Lam A.S., Bonner T.I.;
RT   "Distribution of the GABA(B) receptor subunit gb2 in rat CNS.";
RL   Brain Res. 860:41-52(2000).
RN   [10]
RP   FUNCTION, INTERACTION WITH ATF4, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10924501; DOI=10.1074/jbc.m002727200;
RA   Nehring R.B., Horikawa H.P.M., El Far O., Kneussel M., Brandstatter J.H.,
RA   Stamm S., Wischmeyer E., Betz H., Karschin A.;
RT   "The metabotropic GABAB receptor directly interacts with the activating
RT   transcription factor 4.";
RL   J. Biol. Chem. 275:35185-35191(2000).
RN   [11]
RP   FUNCTION, AND MUTAGENESIS OF SER-247; SER-268 AND SER-269.
RX   PubMed=10692480; DOI=10.1124/mol.57.3.419;
RA   Galvez T., Urwyler S., Prezeau L., Mosbacher J., Joly C., Malitschek B.,
RA   Heid J., Brabet I., Froestl W., Bettler B., Kaupmann K., Pin J.-P.;
RT   "Ca(2+) requirement for high-affinity gamma-aminobutyric acid (GABA)
RT   binding at GABA(B) receptors: involvement of serine 269 of the GABA(B)R1
RT   subunit.";
RL   Mol. Pharmacol. 57:419-426(2000).
RN   [12]
RP   INTERACTION WITH JAKMIP1, AND SUBCELLULAR LOCATION.
RX   PubMed=14718537; DOI=10.1074/jbc.m311737200;
RA   Couve A., Restituito S., Brandon J.M., Charles K.J., Bawagan H.,
RA   Freeman K.B., Pangalos M.N., Calver A.R., Moss S.J.;
RT   "Marlin-1, a novel RNA-binding protein associates with GABA receptors.";
RL   J. Biol. Chem. 279:13934-13943(2004).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-929, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-83 AND ASN-439, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24090084; DOI=10.1021/pr400783j;
RA   Parker B.L., Thaysen-Andersen M., Solis N., Scott N.E., Larsen M.R.,
RA   Graham M.E., Packer N.H., Cordwell S.J.;
RT   "Site-specific glycan-peptide analysis for determination of N-glycoproteome
RT   heterogeneity.";
RL   J. Proteome Res. 12:5791-5800(2013).
RN   [15] {ECO:0007744|PDB:1SRZ, ECO:0007744|PDB:1SS2}
RP   STRUCTURE BY NMR OF 96-159, AND DISULFIDE BONDS.
RX   PubMed=15304491; DOI=10.1074/jbc.m406540200;
RA   Blein S., Ginham R., Uhrin D., Smith B.O., Soares D.C., Veltel S.,
RA   McIlhinney R.A., White J.H., Barlow P.N.;
RT   "Structural analysis of the complement control protein (CCP) modules of
RT   GABA(B) receptor 1a: only one of the two CCP modules is compactly folded.";
RL   J. Biol. Chem. 279:48292-48306(2004).
CC   -!- FUNCTION: Component of a heterodimeric G-protein coupled receptor for
CC       GABA, formed by GABBR1 and GABBR2 (PubMed:9872315, PubMed:9872317,
CC       PubMed:9872744). Within the heterodimeric GABA receptor, only GABBR1
CC       seems to bind agonists, while GABBR2 mediates coupling to G proteins
CC       (PubMed:10658574, PubMed:9872317). Ligand binding causes a conformation
CC       change that triggers signaling via guanine nucleotide-binding proteins
CC       (G proteins) and modulates the activity of down-stream effectors, such
CC       as adenylate cyclase (PubMed:10075644, PubMed:10924501, PubMed:9872315,
CC       PubMed:9872744). Signaling inhibits adenylate cyclase, stimulates
CC       phospholipase A2, activates potassium channels, inactivates voltage-
CC       dependent calcium-channels and modulates inositol phospholipid
CC       hydrolysis (PubMed:10457184, PubMed:10692480, PubMed:10924501,
CC       PubMed:9069281, PubMed:9872315, PubMed:9872744). Calcium is required
CC       for high affinity binding to GABA (PubMed:10692480). Plays a critical
CC       role in the fine-tuning of inhibitory synaptic transmission
CC       (PubMed:9872744). Pre-synaptic GABA receptor inhibits neurotransmitter
CC       release by down-regulating high-voltage activated calcium channels,
CC       whereas postsynaptic GABA receptor decreases neuronal excitability by
CC       activating a prominent inwardly rectifying potassium (Kir) conductance
CC       that underlies the late inhibitory postsynaptic potentials
CC       (PubMed:10692480, PubMed:10924501, PubMed:9872744). Not only implicated
CC       in synaptic inhibition but also in hippocampal long-term potentiation,
CC       slow wave sleep, muscle relaxation and antinociception (By similarity).
CC       {ECO:0000250|UniProtKB:Q9UBS5, ECO:0000269|PubMed:10075644,
CC       ECO:0000269|PubMed:10457184, ECO:0000269|PubMed:10658574,
CC       ECO:0000269|PubMed:10692480, ECO:0000269|PubMed:10924501,
CC       ECO:0000269|PubMed:9069281, ECO:0000269|PubMed:9872315,
CC       ECO:0000269|PubMed:9872744}.
CC   -!- SUBUNIT: Heterodimer of GABBR1 and GABBR2 (PubMed:9872315,
CC       PubMed:9872317, PubMed:9872744). Homodimers may form, but are inactive
CC       (PubMed:9872317). Interacts (via C-terminus) with ATF4 (via leucine
CC       zipper domain) (PubMed:10924501). Interacts with JAKMIP1
CC       (PubMed:14718537). {ECO:0000269|PubMed:10924501,
CC       ECO:0000269|PubMed:14718537, ECO:0000269|PubMed:9872315,
CC       ECO:0000269|PubMed:9872317, ECO:0000269|PubMed:9872744}.
CC   -!- INTERACTION:
CC       Q9Z0U4; O88871: Gabbr2; NbExp=8; IntAct=EBI-7090268, EBI-7090239;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10457184,
CC       ECO:0000269|PubMed:14718537, ECO:0000269|PubMed:9069281,
CC       ECO:0000269|PubMed:9872315}; Multi-pass membrane protein {ECO:0000305}.
CC       Postsynaptic cell membrane {ECO:0000269|PubMed:10924501}; Multi-pass
CC       membrane protein {ECO:0000305}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:10924501, ECO:0000269|PubMed:9872317}. Perikaryon
CC       {ECO:0000269|PubMed:14718537}. Note=Coexpression of GABBR1 and GABBR2
CC       is required for GABBR1 maturation and transport to the plasma membrane
CC       (PubMed:10457184). Colocalizes with ATF4 in hippocampal neuron
CC       dendritic membranes (PubMed:10924501). {ECO:0000269|PubMed:10924501,
CC       ECO:0000305|PubMed:10457184}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1A {ECO:0000303|PubMed:9069281};
CC         IsoId=Q9Z0U4-2; Sequence=Displayed;
CC       Name=1E {ECO:0000303|PubMed:10457184}; Synonyms=1C
CC       {ECO:0000303|PubMed:10457184};
CC         IsoId=Q9Z0U4-1; Sequence=VSP_062373;
CC       Name=1B {ECO:0000303|PubMed:9069281};
CC         IsoId=Q9Z0U4-3; Sequence=VSP_062372;
CC       Name=1C {ECO:0000303|PubMed:9875211};
CC         IsoId=Q9Z0U4-4; Sequence=VSP_062372, VSP_062373;
CC       Name=1D {ECO:0000303|PubMed:9875211};
CC         IsoId=Q9Z0U4-5; Sequence=VSP_062372, VSP_062374, VSP_062375;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed in tissues including the
CC       forebrain, cerebellum, eye, atrium, ventricle, lung, stomach, small
CC       intestine, colon, liver, spleen, kidney, urinary bladder and skeletal
CC       muscle (PubMed:9875211). Expressed at low levels in testis, and more
CC       highly in brain regions (PubMed:9069281). Expression is high the brain
CC       regions including cerebral cortical layers, with higher expression in
CC       VIb than in the II-V layers, pyramidal CA1-CA3 cell layers and granular
CC       cell layers of the hippocampus, granular cell layers of the dentate
CC       gyrus, including the caudate, putamen, nucleus accumbens and olfactory
CC       tubercle, the granular layer cell layers of the medial habenula, in the
CC       cerebellum, predominantly in Purkinje cells, and in the granule cell
CC       layer (PubMed:10727622, PubMed:9069281, PubMed:9872315,
CC       PubMed:9872744). Also expressed in areas of the brain including the
CC       medial geniculate nucleus, substantia nigra, pars compacta, the ventral
CC       tegmental area, and in several thalamic, amygdaloid and hypothalamic
CC       nuclei, such as the arcuate nucleus of the hypothalamus and mammilary
CC       bodies of the hypothalamus (PubMed:9069281, PubMed:9872744). Expressed
CC       in the amacrine cell of the retina (PubMed:10924501).
CC       {ECO:0000269|PubMed:10727622, ECO:0000269|PubMed:10924501,
CC       ECO:0000269|PubMed:9069281, ECO:0000269|PubMed:9872315,
CC       ECO:0000269|PubMed:9872744, ECO:0000269|PubMed:9875211}.
CC   -!- TISSUE SPECIFICITY: [Isoform 1A]: Expressed in the brain, spinal cord,
CC       stomach, testis, adrenal gland, pituitary, spleen and prostate.
CC       {ECO:0000269|PubMed:10658574}.
CC   -!- TISSUE SPECIFICITY: [Isoform 1B]: Expressed in the brain, spinal cord,
CC       stomach, testis, kidney and liver. {ECO:0000269|PubMed:10658574}.
CC   -!- TISSUE SPECIFICITY: [Isoform 1C]: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:9875211}.
CC   -!- TISSUE SPECIFICITY: [Isoform 1D]: Expressed in the forebrain,
CC       cerebellum, eye, kidney and urinary bladder.
CC       {ECO:0000269|PubMed:9875211}.
CC   -!- TISSUE SPECIFICITY: [Isoform 1E]: Ubiquitously expressed with high
CC       expression in the pyramidal CA1-CA3 cell layers of the hippocampus, the
CC       granule cell layers of the dentate gyrus and olfactory tubercle, the
CC       whole cortex, and Purkinje cells of the cerebellum. Moderate expression
CC       in the granule cell layer of the cerebellum.
CC       {ECO:0000269|PubMed:10457184}.
CC   -!- DEVELOPMENTAL STAGE: At 17 dpc during embryonic development, highly
CC       expressed in brain regions including the striatum, olfactory bulb,
CC       septal nuclei, lateral habenula, pyramidal CA1-CA2 cell layers of the
CC       hippocampus and in the neuroepithelial cells of the ventricular zone.
CC       On the day of birth, expressed in the regions of the brain including
CC       hippocampus, thalamic nuclei, cortex and cerebellum.
CC       {ECO:0000269|PubMed:9872744}.
CC   -!- DOMAIN: Alpha-helical parts of the C-terminal intracellular region
CC       mediate heterodimeric interaction with GABBR2. The linker region
CC       between the transmembrane domain 3 (TM3) and the transmembrane domain 4
CC       (TM4) probably plays a role in the specificity for G-protein coupling.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 3 family. GABA-B
CC       receptor subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y10369; CAA71398.1; -; mRNA.
DR   EMBL; Y10370; CAA71399.1; -; mRNA.
DR   EMBL; AB016160; BAA34708.1; -; mRNA.
DR   EMBL; AB016161; BAA34709.1; -; mRNA.
DR   EMBL; AH007482; AAD19656.1; -; Genomic_DNA.
DR   EMBL; AF110796; AAD19656.1; JOINED; Genomic_DNA.
DR   EMBL; AH007482; AAD19657.1; -; Genomic_DNA.
DR   EMBL; AF110796; AAD19657.1; JOINED; Genomic_DNA.
DR   EMBL; AH007482; AAD19658.1; -; Genomic_DNA.
DR   EMBL; AF110796; AAD19658.1; JOINED; Genomic_DNA.
DR   EMBL; AH007482; AAD19659.1; -; Genomic_DNA.
DR   EMBL; AF110796; AAD19659.1; JOINED; Genomic_DNA.
DR   RefSeq; NP_112290.2; NM_031028.3. [Q9Z0U4-2]
DR   RefSeq; XP_006255941.1; XM_006255879.3. [Q9Z0U4-1]
DR   PDB; 1SRZ; NMR; -; A=96-159.
DR   PDB; 1SS2; NMR; -; A=96-159.
DR   PDBsum; 1SRZ; -.
DR   PDBsum; 1SS2; -.
DR   AlphaFoldDB; Q9Z0U4; -.
DR   BMRB; Q9Z0U4; -.
DR   SMR; Q9Z0U4; -.
DR   BioGRID; 249557; 2.
DR   ComplexPortal; CPX-404; GABA-B receptor complex.
DR   CORUM; Q9Z0U4; -.
DR   IntAct; Q9Z0U4; 2.
DR   MINT; Q9Z0U4; -.
DR   STRING; 10116.ENSRNOP00000047788; -.
DR   BindingDB; Q9Z0U4; -.
DR   ChEMBL; CHEMBL2753; -.
DR   DrugCentral; Q9Z0U4; -.
DR   GuidetoPHARMACOLOGY; 240; -.
DR   GlyCosmos; Q9Z0U4; 7 sites, 2 glycans.
DR   GlyGen; Q9Z0U4; 7 sites, 2 N-linked glycans (2 sites).
DR   iPTMnet; Q9Z0U4; -.
DR   PhosphoSitePlus; Q9Z0U4; -.
DR   PaxDb; 10116-ENSRNOP00000047788; -.
DR   ABCD; Q9Z0U4; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000085050.2; ENSRNOP00000075181.2; ENSRNOG00000000774.9. [Q9Z0U4-1]
DR   Ensembl; ENSRNOT00000088396.2; ENSRNOP00000072226.1; ENSRNOG00000000774.9. [Q9Z0U4-3]
DR   Ensembl; ENSRNOT00000090936.2; ENSRNOP00000071413.2; ENSRNOG00000000774.9. [Q9Z0U4-2]
DR   Ensembl; ENSRNOT00055015250; ENSRNOP00055012209; ENSRNOG00055009006. [Q9Z0U4-1]
DR   Ensembl; ENSRNOT00060005505; ENSRNOP00060004025; ENSRNOG00060003245. [Q9Z0U4-1]
DR   Ensembl; ENSRNOT00065046663; ENSRNOP00065038265; ENSRNOG00065026733. [Q9Z0U4-1]
DR   GeneID; 81657; -.
DR   KEGG; rno:81657; -.
DR   UCSC; RGD:621537; rat. [Q9Z0U4-2]
DR   AGR; RGD:621537; -.
DR   CTD; 2550; -.
DR   RGD; 621537; Gabbr1.
DR   eggNOG; KOG1055; Eukaryota.
DR   GeneTree; ENSGT00940000157642; -.
DR   InParanoid; Q9Z0U4; -.
DR   OMA; WAGGEAC; -.
DR   OrthoDB; 2970339at2759; -.
DR   PhylomeDB; Q9Z0U4; -.
DR   TreeFam; TF313965; -.
DR   Reactome; R-RNO-1296041; Activation of G protein gated Potassium channels.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   Reactome; R-RNO-420499; Class C/3 (Metabotropic glutamate/pheromone receptors).
DR   Reactome; R-RNO-977444; GABA B receptor activation.
DR   Reactome; R-RNO-997272; Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits.
DR   EvolutionaryTrace; Q9Z0U4; -.
DR   PRO; PR:Q9Z0U4; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000000774; Expressed in frontal cortex and 20 other cell types or tissues.
DR   ExpressionAtlas; Q9Z0U4; baseline and differential.
DR   GO; GO:0030673; C:axolemma; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:1902712; C:G protein-coupled GABA receptor complex; IPI:ComplexPortal.
DR   GO; GO:0038037; C:G protein-coupled receptor dimeric complex; ISO:RGD.
DR   GO; GO:0038039; C:G protein-coupled receptor heterodimeric complex; ISS:UniProtKB.
DR   GO; GO:1902710; C:GABA receptor complex; IDA:CAFA.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:CAFA.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0097060; C:synaptic membrane; IDA:CAFA.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
DR   GO; GO:1990430; F:extracellular matrix protein binding; IMP:CAFA.
DR   GO; GO:0004965; F:G protein-coupled GABA receptor activity; IDA:RGD.
DR   GO; GO:0099579; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0150047; F:G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:CAFA.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; IDA:MGI.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IDA:ComplexPortal.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0033602; P:negative regulation of dopamine secretion; IDA:RGD.
DR   GO; GO:0032811; P:negative regulation of epinephrine secretion; IMP:RGD.
DR   GO; GO:0014053; P:negative regulation of gamma-aminobutyric acid secretion; IMP:RGD.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IDA:RGD.
DR   GO; GO:0150099; P:neuron-glial cell signaling; IGI:ARUK-UCL.
DR   GO; GO:0001649; P:osteoblast differentiation; IMP:RGD.
DR   GO; GO:0014049; P:positive regulation of glutamate secretion; IMP:RGD.
DR   GO; GO:0060124; P:positive regulation of growth hormone secretion; IMP:RGD.
DR   GO; GO:0014048; P:regulation of glutamate secretion; IDA:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0051932; P:synaptic transmission, GABAergic; NAS:ComplexPortal.
DR   CDD; cd15291; 7tmC_GABA-B-R1; 1.
DR   CDD; cd00033; CCP; 1.
DR   CDD; cd06366; PBP1_GABAb_receptor; 1.
DR   Gene3D; 3.40.50.2300; -; 2.
DR   Gene3D; 2.10.70.10; Complement Module, domain 1; 1.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR002455; GPCR3_GABA-B.
DR   InterPro; IPR017978; GPCR_3_C.
DR   InterPro; IPR002456; GPCR_3_GABA_rcpt_B1.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR035976; Sushi/SCR/CCP_sf.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   PANTHER; PTHR10519; GABA-B RECEPTOR; 1.
DR   PANTHER; PTHR10519:SF76; GAMMA-AMINOBUTYRIC ACID TYPE B RECEPTOR SUBUNIT 1; 1.
DR   Pfam; PF00003; 7tm_3; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00084; Sushi; 1.
DR   PRINTS; PR01177; GABAB1RECPTR.
DR   PRINTS; PR01176; GABABRECEPTR.
DR   SMART; SM00032; CCP; 2.
DR   SUPFAM; SSF57535; Complement control module/SCR domain; 2.
DR   SUPFAM; SSF53822; Periplasmic binding protein-like I; 1.
DR   PROSITE; PS50259; G_PROTEIN_RECEP_F3_4; 1.
DR   PROSITE; PS50923; SUSHI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cell projection;
KW   Coiled coil; Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Membrane; Phosphoprotein; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Repeat; Signal; Synapse; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..960
FT                   /note="Gamma-aminobutyric acid type B receptor subunit 1"
FT                   /id="PRO_0000012951"
FT   TOPO_DOM        20..590
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        591..611
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        612..630
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        631..651
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        652..666
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        667..687
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        688..709
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        710..730
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        731..767
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        768..788
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        789..803
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        804..824
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        825..832
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        833..853
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        854..960
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          29..95
FT                   /note="Sushi 1"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          97..158
FT                   /note="Sushi 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   REGION          866..891
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          887..915
FT                   /note="Interaction with ATF4"
FT                   /evidence="ECO:0000269|PubMed:10924501"
FT   REGION          908..960
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          870..924
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        866..883
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        926..940
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         246
FT                   /ligand="4-aminobutanoate"
FT                   /ligand_id="ChEBI:CHEBI:59888"
FT                   /ligand_note="agonist"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UBS5"
FT   BINDING         269
FT                   /ligand="4-aminobutanoate"
FT                   /ligand_id="ChEBI:CHEBI:59888"
FT                   /ligand_note="agonist"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UBS5"
FT   BINDING         286
FT                   /ligand="4-aminobutanoate"
FT                   /ligand_id="ChEBI:CHEBI:59888"
FT                   /ligand_note="agonist"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UBS5"
FT   BINDING         366
FT                   /ligand="4-aminobutanoate"
FT                   /ligand_id="ChEBI:CHEBI:59888"
FT                   /ligand_note="agonist"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UBS5"
FT   BINDING         465
FT                   /ligand="4-aminobutanoate"
FT                   /ligand_id="ChEBI:CHEBI:59888"
FT                   /ligand_note="agonist"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UBS5"
FT   MOD_RES         872
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WV18"
FT   MOD_RES         929
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        23
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        83
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        408
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        439
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        481
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        501
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        513
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        99..144
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302,
FT                   ECO:0000269|PubMed:15304491, ECO:0007744|PDB:1SRZ,
FT                   ECO:0007744|PDB:1SS2"
FT   DISULFID        130..156
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302,
FT                   ECO:0000269|PubMed:15304491, ECO:0007744|PDB:1SRZ,
FT                   ECO:0007744|PDB:1SS2"
FT   DISULFID        219..245
FT                   /evidence="ECO:0000250|UniProtKB:Q9UBS5"
FT   DISULFID        375..409
FT                   /evidence="ECO:0000250|UniProtKB:Q9UBS5"
FT   VAR_SEQ         1..163
FT                   /note="MLLLLLVPLFLRPLGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQVKA
FT                   INFLPVDYEIEYVCRGEREVVGPKVRKCLANGSWTDMDTPSRCVRICSKSYLTLENGKV
FT                   FLTGGDLPALDGARVEFRCDPDFHLVGSSRSVCSQGQWSTPKPHCQVNRTPH -> MGP
FT                   GGPCTPVGWPLPLLLVMAAGVAPVWASHSPHLPRPHPRVPPHPS (in isoform
FT                   1B, isoform 1C and isoform 1D)"
FT                   /evidence="ECO:0000269|PubMed:9069281,
FT                   ECO:0000269|PubMed:9875211"
FT                   /id="VSP_062372"
FT   VAR_SEQ         770
FT                   /note="G -> GELWSFAVSSDVQRRATVGGDSPICVWPAPES (in isoform 1C
FT                   and isoform 1E)"
FT                   /evidence="ECO:0000269|PubMed:10457184"
FT                   /id="VSP_062373"
FT   VAR_SEQ         904..928
FT                   /note="KEERVSELRHQLQSRQQLRSRRHPP -> VCGDKQPGPPVSEGGLPVVGPSI
FT                   EV (in isoform 1D)"
FT                   /evidence="ECO:0000269|PubMed:9875211"
FT                   /id="VSP_062374"
FT   VAR_SEQ         929..960
FT                   /note="Missing (in isoform 1D)"
FT                   /evidence="ECO:0000269|PubMed:9875211"
FT                   /id="VSP_062375"
FT   MUTAGEN         247
FT                   /note="S->A: No change in the affinity for GABA."
FT                   /evidence="ECO:0000269|PubMed:10692480"
FT   MUTAGEN         268
FT                   /note="S->A: No change in the affinity for GABA."
FT                   /evidence="ECO:0000269|PubMed:10692480"
FT   MUTAGEN         269
FT                   /note="S->A: Decrease in the affinity for GABA."
FT                   /evidence="ECO:0000269|PubMed:10692480"
FT   STRAND          96..98
FT                   /evidence="ECO:0007829|PDB:1SRZ"
FT   HELIX           101..104
FT                   /evidence="ECO:0007829|PDB:1SRZ"
FT   STRAND          109..112
FT                   /evidence="ECO:0007829|PDB:1SRZ"
FT   TURN            120..123
FT                   /evidence="ECO:0007829|PDB:1SRZ"
FT   STRAND          125..130
FT                   /evidence="ECO:0007829|PDB:1SRZ"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:1SRZ"
FT   STRAND          141..145
FT                   /evidence="ECO:0007829|PDB:1SRZ"
FT   STRAND          148..151
FT                   /evidence="ECO:0007829|PDB:1SRZ"
FT   STRAND          156..158
FT                   /evidence="ECO:0007829|PDB:1SRZ"
SQ   SEQUENCE   960 AA;  108204 MW;  05B7FBBCBE9DBF94 CRC64;
     MLLLLLVPLF LRPLGAGGAQ TPNATSEGCQ IIHPPWEGGI RYRGLTRDQV KAINFLPVDY
     EIEYVCRGER EVVGPKVRKC LANGSWTDMD TPSRCVRICS KSYLTLENGK VFLTGGDLPA
     LDGARVEFRC DPDFHLVGSS RSVCSQGQWS TPKPHCQVNR TPHSERRAVY IGALFPMSGG
     WPGGQACQPA VEMALEDVNS RRDILPDYEL KLIHHDSKCD PGQATKYLYE LLYNDPIKII
     LMPGCSSVST LVAEAARMWN LIVLSYGSSS PALSNRQRFP TFFRTHPSAT LHNPTRVKLF
     EKWGWKKIAT IQQTTEVFTS TLDDLEERVK EAGIEITFRQ SFFSDPAVPV KNLKRQDARI
     IVGLFYETEA RKVFCEVYKE RLFGKKYVWF LIGWYADNWF KTYDPSINCT VEEMTEAVEG
     HITTEIVMLN PANTRSISNM TSQEFVEKLT KRLKRHPEET GGFQEAPLAY DAIWALALAL
     NKTSGGGGRS GVRLEDFNYN NQTITDQIYR AMNSSSFEGV SGHVVFDASG SRMAWTLIEQ
     LQGGSYKKIG YYDSTKDDLS WSKTDKWIGG SPPADQTLVI KTFRFLSQKL FISVSVLSSL
     GIVLAVVCLS FNIYNSHVRY IQNSQPNLNN LTAVGCSLAL AAVFPLGLDG YHIGRSQFPF
     VCQARLWLLG LGFSLGYGSM FTKIWWVHTV FTKKEEKKEW RKTLEPWKLY ATVGLLVGMD
     VLTLAIWQIV DPLHRTIETF AKEEPKEDID VSILPQLEHC SSKKMNTWLG IFYGYKGLLL
     LLGIFLAYET KSVSTEKIND HRAVGMAIYN VAVLCLITAP VTMILSSQQD AAFAFASLAI
     VFSSYITLVV LFVPKMRRLI TRGEWQSETQ DTMKTGSSTN NNEEEKSRLL EKENRELEKI
     IAEKEERVSE LRHQLQSRQQ LRSRRHPPTP PDPSGGLPRG PSEPPDRLSC DGSRVHLLYK
//
